Use of nomegestrol acetate in the treatment of menstrual disorders. Our experience of 56 patients;Utilizzo del nomegestrolo acetato nella terapia delle irregolarita mestruali. Esperienza di 56 casi

Minerva Ginecologica

Volumn 49, Issue 4, 1997, Pages 181-185

  Persiani, P ^a   Radici, E ^a   Lombardi, P A ^a   Lombardi, P L ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

Amenorrhea; Menstruation disorders; Oligomenorrhea; Polymenorrhea; Premenstrual syndrome; Progesterone, derivatives

Indexed keywords

ALGESTONE ACETOFENIDE; NOMEGESTROL ACETATE;

ADULT; AMENORRHEA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; OLIGOMENORRHEA; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0030981897     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Campagnoli C, Cantamessa C, Lesca L, Peris C. Progestinici nell'ambito di terapie estrogeniche sostitutive: biochimica ed effetti metabolici. Curr Obstet Ginecol 1993;1:34-9.
2. Thomas JL, Leclere J, Hatemann P. Les progestatifs - Effects biologiques et implications thérapeutiques. Rev Franc Endocrinol Clin 1986;27:338.
3. Bazin B, Thevenot R, Bursaux C, Paris J. Effects of nomegestrol acetate, a new 19-nor-progesterone derivative, on pituitary-ovarian function in women. Br J Obstet Gynecol 1987;94.1199.
4. Botella J, Duc I, Delansorne R, Paris J, Lahlou B. Structure activity and structure affinity relationships of 19-nor-progesterone derivatives in rat uterus. J Endocrinol Invest 1990;13(11):905.
5. Botella J, Duc I, Delansorne R, Paris J, Lahlou B. Kinetic analysis of the binding of nomegestrol acetate to the progesterone receptors in rat uterus by competition studies Fundam Clin Pharmacol 1990, 4(5).511
6. Basdevant A. Pelissier C, Conard J, Degrelle H, Guyene TT, Thomas JL Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and hemostatic parameters in premenopausal women. Contraception 1991;44(6):599.
7. Dorangenon P, Thomas JL, Choisy H, Lumbroso M, Hazard MC Effects of nomegestrol acetate on carbohydrate metabolism. Diabete Metab 1993,19(5):441.
8. Pans J, Thevenot R, Bonnet P, Granero M. The pharmacological profile of TX 066 (17-α-acetoxy-6-metil119-nor-4,6-pregnandiene-3,20-dione), a new oral progestative. Areneim Forsch Drug Res 1983;33:710
9. Paris J Extinction of mineralcorticoid effects in 19-nor-progesterone derivatives: activity relationship. J Pharm Experim Ther 1987,243:288.
10. De Ziegler D, Zartarian M, Micheletti MC, Linh CG, Schaerer E. L'administration cyclique de nomegestrol acetate n'altere pas les effects vasodilatateurs de l'estradiol sur l'artetre uterine. Contracept Fertil Sex 1994,22(12):767.
11. Botella J. Duranti E, Duc I, Cogner AM, Delansorne R, Paris J. Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T47-D human breast cancer cells J Steroid Biochem Mol Biol 1994;50(1-2), 41.